MedPath

Effects of transcutaneous electrical nerve stimulation to cancer-related pai

Not Applicable
Conditions
Cancer
Registration Number
JPRN-UMIN000028274
Lead Sponsor
agasaki University
Brief Summary

Finally, 20 patients completed the study. When the average pain NRS score during the day were compared between pre- and post- intervention, there was a significant reduction in the score during the TENS-phase (p < 0.01). When the scores of physical symptoms were compared between pre- and post-intervention, a significant reduction in pain (p < 0.01), nausea/vomiting (p = 0.04), and appetite loss (p = 0.02) was shown in the TENS-phase.

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
20
Inclusion Criteria

Not provided

Exclusion Criteria

The patient who was judged to be inadequate by chief physician. The patient that overall status is poor. The patient who puts on internal implantation such as pacemakers-type electronic equipment. The patient who has a severe ischemic disorder. The patient with the inguinal hernia. The pregnant patient. The patient who has electric allergia. The patient whom cutaneous abnormality is found in the back. The patient who has difficulty with communication.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Pain(Numerical Rating Scale: NRS)(pre- and post TENS)
Secondary Outcome Measures
NameTimeMethod
Kind and quantity of analgesic(pre- and post TENS) The number of rescue-dose(during TENS-period) Degree of nausea and constipation(pre- and post TENS) The number of vomitting(during TENS-period) Stool frequency (during TENS-period) ECOG Performance Status(pre- and post TENS) Activity(the number of steps)(during TENS-period) quality of life (QOL): EORTC QLQ-C15-PAL(pre- and post TENS)
© Copyright 2025. All Rights Reserved by MedPath